Dirk Garmann
Impact in
- Internal Medicine top 10%
- Hematology top 10%
- Hemophilia Treatment and Research
Papers in
-
- Pharmaceutical studies and practices 9
-
- Statistical Methods in Clinical Trials 5
- Co-authors
- Ulrich Jaehde (4 shared papers)André Warnecke (2 shared papers)Felix Kratz (2 shared papers)Alexander Solms (11 shared papers)Ganna V. Kalayda (2 shared papers)Iduna Fichtner (1 shared paper)Anita Shah (3 shared papers)Bart A. Ploeger (3 shared papers)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (8 papers)Clinical Pharmacokinetics (7 papers)Journal of Thrombosis and Thrombolysis (2 papers)Clinical Pharmacology & Therapeutics (2 papers)The Journal of Clinical Pharmacology (2 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Dirk Garmann
29 papers receiving 586 citations
Peers
Comparison fields: 5 of 54
- Internal Medicine 27
- Hematology 112
- Oncology 128
- Nephrology 53
- Cardiology and Cardiovascular Medicine 90
Countries citing papers authored by Dirk Garmann
This map shows the geographic impact of Dirk Garmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Garmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Garmann more than expected).
Fields of papers citing papers by Dirk Garmann
This network shows the impact of papers produced by Dirk Garmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Garmann. The network helps show where Dirk Garmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Garmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 94 | |
| 2 | 2008 | 75 | |
| 3 | 2018 | 58 | |
| 4 | 2011 | 36 | |
| 5 | 2021 | 36 | |
| 6 | 2017 | 35 | |
| 7 | 2016 | 33 | |
| 8 | 2018 | 29 | |
| 9 | 2019 | 26 | |
| 10 | 2019 | 24 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 15 | |
| 14 | 2019 | 14 | |
| 15 | 2023 | 14 | |
| 16 | 2020 | 11 | |
| 17 | 2019 | 10 | |
| 18 | 2010 | 8 | |
| 19 | 2019 | 8 | |
| 20 | 2019 | 7 |
About Dirk Garmann
Dirk Garmann is a scholar working on Pediatrics, Perinatology and Child Health, Statistics and Probability, Hematology, Nephrology and Cardiology and Cardiovascular Medicine, having authored 31 papers that have together received 600 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (9 papers), Hemophilia Treatment and Research (5 papers), Statistical Methods in Clinical Trials (5 papers), Chronic Kidney Disease and Diabetes (4 papers), Metal complexes synthesis and properties (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Potassium and Related Disorders (2 papers) and Heart Failure Treatment and Management (2 papers). The work is most often cited by research in Internal Medicine (27 citations), Hematology (112 citations), Oncology (128 citations), Nephrology (53 citations) and Cardiology and Cardiovascular Medicine (90 citations). Dirk Garmann has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Ulrich Jaehde, André Warnecke, Felix Kratz, Alexander Solms, Ganna V. Kalayda, Iduna Fichtner, Anita Shah, Bart A. Ploeger, Thomas Eißing and Liping Zhang. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacokinetics, Journal of Thrombosis and Thrombolysis, Clinical Pharmacology & Therapeutics and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.